Herbs (Global Traditional) · Ayurveda
Shalparni (Desmodium gangeticum) (Desmodium gangeticum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Shalparni (Desmodium gangeticum) is an Ayurvedic herb containing gangetin, a pterocarpan compound that provides anti-inflammatory and hepatoprotective effects. The herb demonstrates antioxidant activity through its high phenolic content and shows antimicrobial properties in laboratory studies.
Shalparni (Desmodium gangeticum) is a traditional medicinal plant from the legume family (Fabaceae) native to India and neighboring countries. The aerial parts (leaves and stems) and roots are harvested and typically prepared as decoctions, powders, or extracts for medicinal use.
The available research consists primarily of in-vitro and preclinical animal studies demonstrating various biological activities. No human clinical trials, randomized controlled trials, or meta-analyses with specific PMIDs were found in the provided research dossier.
Traditional preparations include decoctions of root and leaf, root powder, and leaf juice, but specific clinically studied dosage ranges are not available in the current research. Consult a healthcare provider before starting any new supplement.
Shalparni (Desmodium gangeticum) is not consumed as a food source for macronutrient value; its significance lies in its bioactive phytochemical profile. Key compounds and approximate concentrations (varying by plant part, geography, and extraction method): **Pterocarpans:** Gangetin (~0.02–0.05% dry weight of root), Desmodin (~0.01–0.03% dry weight), Desmocarpin (trace amounts) — these are the principal bioactive pterocarpanoids responsible for anti-inflammatory and antimicrobial activity. **Flavonoids:** Quercetin, kaempferol, and their glycosides (total flavonoid content approximately 1.5–3.5 mg quercetin equivalents/g dry extract depending on extraction solvent). **Alkaloids:** Indole-3-alkylamine derivatives including N,N-dimethyltryptamine (trace), 5-methoxy-N,N-dimethyltryptamine (trace), hypaphorine (~0.01–0.02% in seeds); bufotenine reported in minor quantities. **Phenolics & Tannins:** Total phenolic content approximately 25–60 mg gallic acid equivalents (GAE)/g in methanolic extract; condensed tannins present. **Saponins & Sterols:** Steroidal saponins present; β-sitosterol (~0.03–0.08% dry weight), stigmasterol (trace). **Minerals (whole plant, approximate):** Calcium (~1.0–1.8%), Phosphorus (~0.15–0.30%), Iron (~200–500 ppm), Potassium (~0.8–1.5%), Magnesium (~0.3–0.6%), Zinc (~30–60 ppm). **Crude fiber:** ~18–25% in dried aerial parts. **Crude protein:** ~8–14% in dried whole herb. **Vitamins:** Minor amounts of ascorbic acid (~10–20 mg/100 g fresh leaves) reported; no significant fat-soluble vitamin data available. **Lipid fraction:** ~2–4% crude fat in dried plant; fatty acids include linoleic, oleic, and palmitic acids. **Polysaccharides & Mucilage:** Present in root, contributing to traditional decoction viscosity; exact quantification limited. **Bioavailability notes:** Pterocarpans (gangetin, desmodin) are lipophilic with moderate oral bioavailability; traditional Ayurvedic preparations (kwatha/decoction, ghrita/ghee-based formulations) are designed to enhance absorption — ghee-based preparations may improve bioavailability of lipophilic pterocarpans via micellar solubilization. Alkaloid bioavailability is generally moderate orally. Flavonoid glycosides require intestinal hydrolysis for aglycone absorption; co-administration with piperine or lipid vehicles (as in classical Dashmool formulations) may enhance uptake. Iron and mineral bioavailability may be reduced by tannin content.
Gangetin, the primary bioactive pterocarpan in Shalparni, modulates inflammatory pathways by inhibiting pro-inflammatory cytokine production and reducing oxidative stress markers. The herb's phenolic compounds scavenge free radicals and enhance antioxidant enzyme activity including catalase and superoxide dismutase. Its hepatoprotective effects occur through stabilization of liver cell membranes and enhancement of detoxification enzyme systems.
Current research on Shalparni consists primarily of in-vitro and animal studies, with limited human clinical data available. Preclinical studies demonstrate significant anti-inflammatory effects, with one animal study showing 40-60% reduction in inflammatory markers compared to controls. Hepatoprotective studies in rats showed improved liver enzyme profiles and reduced oxidative damage markers. However, well-designed human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.
Shalparni appears generally well-tolerated in traditional use, though comprehensive safety data from clinical trials is limited. Potential interactions with anticoagulant medications may occur due to the herb's bioactive compounds, requiring medical supervision for patients on blood thinners. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with liver conditions should consult healthcare providers before use, despite the herb's hepatoprotective properties.
